Vicore Announces The Nomination Committee For The 2026 Annual General Meeting

STOCKHOLM, SE / ACCESS Newswire / November 3, 2025 / Vicore Pharma Holding (STO:VICO) – Stockholm, November 3, 2025 – Vicore Pharma Holding AB (publ)(STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), has appointed the Nomination Committee for the 2026 Annual General Meeting (AGM). The three […]

Vicore announces the Nomination Committee for the 2026 Annual General Meeting

STOCKHOLM, SE / ACCESS Newswire / November 3, 2025 / Vicore Pharma Holding (STO:VICO) – Stockholm, November 3, 2025 – Vicore Pharma Holding AB (publ)(STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), has appointed the Nomination Committee for the 2026 Annual General Meeting (AGM). The three

Savara Inc. (SVRA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 7, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=175165&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Verizon to redeem debt securities on December 16, 2025

Verizon to redeem debt securities on December 16, 2025 GlobeNewswire November 03, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Verizon Communications Inc. (“Verizon”) (NYSE, NASDAQ: VZ) today announced that it will redeem the following notes on December 16, 2025 (the “Redemption Date”): I.D. Number Title of Security Amountto be Redeemed Principal AmountOutstanding CUSIP:

Actimed Therapeutics Further Expands Intellectual Property Portfolio for Lead Compound with New Composition of Matter Patent in Japan

Actimed Therapeutics Further Expands Intellectual Property Portfolio for Lead Compound with New Composition of Matter Patent in Japan GlobeNewswire November 03, 2025 Patent expands IP protection for S-pindolol benzoate (ACM-001.1), reinforcing the global IP position of Actimed with granted patents in all key markets London, UK – 3 November 2025. Actimed Therapeutics Ltd (“Actimed” or

FED Fitness Early Black Friday Starts Now: Save Up to $425 on Premium Home Gym Gear

FED Fitness Early Black Friday Starts Now: Save Up to $425 on Premium Home Gym Gear GlobeNewswire November 03, 2025 HONG KONG, Nov. 03, 2025 (GLOBE NEWSWIRE) — FED Fitness, a global leader in home fitness solutions, is kicking off the holiday season with its biggest promotion of the year–the 2025 Black Friday Deal Early

Exosome Research Market Size to Reach USD 961.41 Million by 2034

Exosome Research Market Size to Reach USD 961.41 Million by 2034 According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is expected to reach around USD 961.41 million by 2034, growing at a compound annual growth rate (CAGR) of 17.47% over the forecast period

Join Class Action to Recover Losses from KBR, Inc. (KBR) – Contact Levi & Korsinsky Before November 18, 2025

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=175162&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Levi & Korsinsky Notifies Tronox Holdings plc (TROX) Shareholders of Class Action Lawsuit and November 3, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=175160&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Class Action Lawsuit Filed: Cytokinetics, Incorporated (CYTK) – Join by November 17, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=175161&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top